Molecular targeted therapies for cutaneous squamous cell carcinoma: recent developments and clinical implications
Various signaling pathways involved in the pathogenesis and therapeutic strategies of cSCC. (A) RAS signaling pathway, there are two key pathways involved: the MAP kinase pathway and the PI3K pathway. These regulate the cell cycle, death of cells, cell metabolism, and the production of proteins. Green arrows represent activation, whereas red lines represent inhibition. (B) The route of Wnt signaling. Catenin, a critical component of the Wnt pathway, has two roles. It functions as a transcriptional activator in the nucleus, regulating development of cell, as well as a component of cell adhesion junctions. (C) The Hedgehog route. The reaction of hedgehog ligands with the receptors in the membrane. (D) Notch Pathway. Cell-to-cell contact is required for Notch signaling. Notch ligands on a neighboring cell bind to Notch, leading it to undergo degradation by two proteases. This results in the release of the Notch cytoplasmic domain, which then migrates to the nucleus to communicate with transcription factors, reproduced with permission from reference (Juliano, 2020).
Publication
Molecular targeted therapies for cutaneous squamous cell carcinoma: recent developments and clinical implications. (2024) Harpreet Singh, et al. EXCLI J. 2024;23:300-334. Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | Cell2 | CELL2 | ncbigene_synonym | CELP | 1057 |
| Homo sapiens | Primates | Mek | MEK | ncbigene_synonym | MAP2K7 | 5609 |
| Homo sapiens | Primates | Mek | MEK | famplex_relations | MAP2K1 | 5604 |
| Homo sapiens | Primates | Mek | MEK | famplex_relations | MAP2K2 | 5605 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | KRAS | 3845 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | HRAS | 3265 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | NRAS | 4893 |
| Homo sapiens | Primates | AKT | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | Lrp5 | LRP5 | ncbigene_symbol | LRP5 | 4041 |
| Homo sapiens | Primates | Fad | FAD | ncbigene_synonym | BRCA2 | 675 |
| Homo sapiens | Primates | Fad | FAD | ncbigene_synonym | FANCD2 | 2177 |
| Homo sapiens | Primates | Fad | FAD | ncbigene_synonym | PSEN1 | 5663 |
| Homo sapiens | Primates | -Cat | CAT | ncbigene_symbol | CAT | 847 |
| Homo sapiens | Primates | -Cat | CAT | ncbigene_synonym | CRAT | 1384 |
| Homo sapiens | Primates | -Cat | CAT | ncbigene_synonym | GLYAT | 10249 |
| Homo sapiens | Primates | Ck1 | CK1 | ncbigene_synonym | CSNK1A1 | 1452 |
| Homo sapiens | Primates | Ck1 | CK1 | ncbigene_synonym | KRT1 | 3848 |
| Homo sapiens | Primates | Ck1 | CK1 | ncbigene_synonym | CSNK1A1L | 122011 |
| Homo sapiens | Primates | Rheb | RHEB | ncbigene_symbol | RHEB | 6009 |
| Homo sapiens | Primates | Rheb | RHEB | ncbigene_synonym | RHEBP1 | 6008 |
| Homo sapiens | Primates | Tef | TEF | ncbigene_symbol | TEF | 7008 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Mek | MEK | butan-2-one | chebi:28398 | |
| RAS | RAS | (1R)-N-(prop-2-yn-1-yl)indan-1-amine | chebi:63620 | |
| NUCLEUS | nucleus | nucleus | chebi:33252 | |
| NUCLEUS | nucleus | nucleus | chebi:33252 | |
| Protein | Protein | a protein | chebi:16541 | |
| NUCLEUS | nucleus | nucleus | chebi:33252 | |
| NUCLEUS | nucleus | nucleus | chebi:33252 | |
| NUCLEUS | nucleus | nucleus | chebi:33252 | |
| NUCLEUS | nucleus | nucleus | chebi:33252 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|